Stock info Mirati Therapeutics Inc | Filter  Basic-Info

Stock: Mirati Therapeutics Inc (US broad)

Last Price 58.70 Max Price 62.38
Min Price 27.80 1 Year return -59.98
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USAWebsite: www.mirai.com

Sector Review Mirati Therapeutics Inc

Loading...
Year Turnover Total sector Market share
2019 3 141,925 0.00 %
2020 13 170,231 0.01 %
2021 72 252,886 0.03 %
2022 12 238,500 0.01 %
2023 0 0 0.00 %

Advice Mirati Therapeutics Inc

No Records Found




News Mirati Therapeutics Inc

No Records Found

Annual reports Mirati Therapeutics Inc

No Records Found


Profile Mirati Therapeutics Inc

Mirati Therapeutics Inc


The past year yielded positive returns for Mirati Therapeutics Inc investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 83 percent. Over the period 2011-2016 the stock lost a modest 0 percent. The net results between 2011 and 2015 were far from constant and fluctuated between -9,84 million dollars and -64,54 million dollars.

Mirati Therapeutics Inc is mostly active in the health care eq. & services sector. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

Mirati Therapeutics Inc didn't pay out any dividends (in the past 5 years).

Mirati Therapeutics Inc's balance mostly consists of debt

At the end of 2015 the American company had a balance sheet of 128,02 million dollars. The total debt was around 9,84 million dollars. This is 7,69 percent of the total balance sheet. As per the end of 2015 Mirati Therapeutics Inc's price/earnings-ratio equaled -5. So investors paid for 1 stock -5 times the earnings per share of 2015. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 508,41 million dollars. At the end of 2015 around 16,9 million stocks were listed.

All Mirati Therapeutics Inc's annual reports can be found here. More information about Mirati Therapeutics Inc can be found it's website. .


Results Mirati Therapeutics Inc

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
13
3
13
Costs
65
83
70
111
217
371
Profit
-65
-83
-70
-98
-213
-358
Margin of profit
0.0
0.0
0.0
-761.18
-6385.03
-2671.19
ROI
-54.61
-172.06
-49.15
-48.82
-55.78
-26.30

Balance Mirati Therapeutics Inc

Balance
2015
2016
2017
2018
2019
2020
Equity
118
48
143
202
382
1,361
Debt
10
15
14
27
50
115
Total assets
128
63
157
228
432
1,476
Solvency
92.31
76.15
91.12
88.24
88.45
92.19
Cash
122
57
151
223
415
1,390
Cashflow
-51
-68
-65
-70
-148
-272
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-5.15
-4.50
-4.64
-2.61
-2.96
-2.35

Details Mirati Therapeutics Inc

Details
2016
2017
2018
2019
2020
Price
31.60
4.75
18.25
42.42
128.86
Eps
-4.20
-2.78
-3.19
-5.69
-7.96
Price/earnings-ratio
-7.52
-1.71
-5.72
-7.46
-7.37
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.42
5.01
6.20
9.67
26.98
Market to book
0.08
1.05
0.34
0.23
0.46
Cashflow per stock
-3.41
-2.26
-2.15
-3.74
-5.38
Stocks
20
29
33
40
50
Market Cap
630.01
135.96
593.83
1.676.32
2.960.78

Dividend Mirati Therapeutics Inc


Price info Mirati Therapeutics Inc

Date
Price
22 Mar 2024
58.70
18 Mar 2024
58.70
15 Mar 2024
58.70
12 Mar 2024
58.70
11 Mar 2024
58.70
09 Mar 2024
58.70
07 Mar 2024
58.70
01 Mar 2024
58.70
29 Feb 2024
58.70
27 Feb 2024
58.70
22 Feb 2024
58.70
21 Feb 2024
58.70
20 Feb 2024
58.70
15 Feb 2024
58.70
14 Feb 2024
58.70
13 Feb 2024
58.70
09 Feb 2024
58.70
08 Feb 2024
58.70
07 Feb 2024
58.70
06 Feb 2024
58.70
05 Feb 2024
58.70
01 Feb 2024
58.70
31 Jan 2024
58.70
30 Jan 2024
58.70
27 Jan 2024
58.70
25 Jan 2024
58.70
23 Jan 2024
58.70
16 Jan 2024
59.28
11 Jan 2024
58.90
10 Jan 2024
59.04